| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | selumetinib:JQ-1 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | tubastatin A | GDSC1000 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | -0.077 | 0.2 |
| mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | 0.055 | 0.2 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | 0.059 | 0.2 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.052 | 0.2 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.042 | 0.2 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.074 | 0.2 |
| mRNA | AZD7762 | GDSC1000 | pan-cancer | AAC | -0.044 | 0.2 |